Now showing items 1-2 of 2

    • D-Dimer elevation and adverse outcomes. 

      Chi, G; Cohen, A; Daaboul, Y; Gibson, Charles Michael; Goldhaber, SZ; Halaby, R; Harrington, Robert Arthur; ... (18 authors) (J Thromb Thrombolysis, 2015-01)
      D-Dimer is a biomarker of fibrin formation and degradation. While a D-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability ...
    • Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke. 

      Britz, GW; Constable, M; Cox, M; Fonarow, GC; Lin, CB; Olson, DaiWai M; Peterson, Eric David; ... (9 authors) (J Am Heart Assoc, 2015-07-22)
      BACKGROUND: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless, the ability of US hospitals to meet guidelines for intravenous tissue plasminogen activator (tPA) remains suboptimal. What is unclear is ...